Evidence map›Paper›PMID 35458662›Full record

ArticleMolecules (Basel, Switzerland)2022

Attenuation of Scopolamine-Induced Amnesia via Cholinergic Modulation in Mice by Synthetic Curcumin Analogs.

Haya Hussain, Shujaat Ahmad, Syed Wadood Ali Shah, Abid Ullah, Niaz Ali, Mazen Almehmadi, Manzoor Ahmad, Atif Ali Khan Khalil, Syed Babar Jamal, Hanif Ahmad and 1 more

Open access · goldAbstract read
In one paragraph

Article in Molecules (Basel, Switzerland), 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 25 papers.

0numbers the graph read from it
0cells of the map it votes in
25citing papers in PubMed
2.4field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

25 citing papers in PubMed, 34 citations in OpenAlex.

  1. Curcumin analogues suppress cellular pro-inflammatory mediators and reduce edema.Naunyn-Schmiedeberg's archives of pharmacology · 2026
    Article
  2. Chemical constituents in the rhizome of Curcuma longa and the pharmacological importance of curcumin hybrids.Medicinal chemistry research : an international journal for rapid communications on design and mechanisms of action of biologically active agents · 2026
    Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Antiamnesic and Neurotrophic Effects ofBehavioural neurology · 2025
    Article
  10. Article
  11. Article
  12. Article
  13. Review
  14. Article
  15. Review
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 6 institutions in 2 countries.

Haya HussainDepartment of Pharmacy, Shaheed Benazir Bhutto University Sheringal Dir (Upper), Dir 18000, Pakistan.ORCID 0000-0001-6121-5441
Shujaat AhmadDepartment of Pharmacy, Shaheed Benazir Bhutto University Sheringal Dir (Upper), Dir 18000, Pakistan.ORCID 0000-0002-4449-6525
Syed Wadood Ali ShahDepartment of Pharmacy, University of Malakand Dir (Lower), Chakdara 18800, Pakistan.ORCID 0000-0001-8143-2363
Abid UllahDepartment of Pharmacy, Shaheed Benazir Bhutto University Sheringal Dir (Upper), Dir 18000, Pakistan.
Niaz AliDepartment of Pharmacology, Institute of Basic Medical Sciences (IBMS), Khyber Medical University, Peshawar 25000, Pakistan.
Mazen AlmehmadiDepartment of Clinical Laboratory Sciences, College of Applied Medical Sciences, Taif University, P.O. Box 11099, Taif 21944, Saudi Arabia.ORCID 0000-0002-7580-8667
Manzoor AhmadDepartment of Chemistry, University of Malakand Dir (Lower), Chakdara 18800, Pakistan.
Atif Ali Khan KhalilDepartment of Biological Sciences, National University of Medical Sciences, Rawalpindi 46000, Pakistan.ORCID 0000-0003-1450-5635
Syed Babar JamalDepartment of Biological Sciences, National University of Medical Sciences, Rawalpindi 46000, Pakistan.ORCID 0000-0001-6916-7376
Hanif AhmadDepartment of Chemistry, University of Malakand Dir (Lower), Chakdara 18800, Pakistan.
Mustafa HalawiDepartment of Medical Laboratory technology, College of Applied Medical Sciences, Jazan University, Jazan 45142, Saudi Arabia.
Shaheed Benazir Bhutto University · PKUniversity of Malakand · PKNational University of Medical Sciences · PKJazan University · SAShaqra University · SATaif University · SA

Funding

Taif University Researchers Supporting Project number: TURSP-2020/80) TURSP-2020/80
6 · The paper itself

Abstract

Alzheimer’s disease is an emerging health disorder associated with cognitive decline and memory loss. In this study, six curcumin analogs (1a−1f) were synthesized and screened for in vitro cholinesterase inhibitory potential. On the basis of promising results, they were further investigated for in vivo analysis using elevated plus maze (EPM), Y-maze, and novel object recognition (NOR) behavioral models. The binding mode of the synthesized compounds with the active sites of cholinesterases, and the involvement of the cholinergic system in brain hippocampus was determined. The synthesized curcumin analog 1d (p < 0.001, n = 6), and 1c (p < 0.01, n = 6) showed promising results by decreasing retention time in EPM, significantly increasing % SAP in Y-maze, while significantly (p < 0.001) enhancing the % discrimination index (DI) and the time exploring the novel objects in NORT mice behavioral models. A molecular docking study using MOE software was used for validation of the inhibition of cholinesterase(s). It has been indicated from the current research work that the synthesized curcumin analogs enhanced memory functions in mice models and could be used as valuable therapeutic molecules against neurodegenerative disorders. To determine their exact mechanism of action, further studies are suggested.

Indexed as

CurcuminScopolamineAcetylcholinesteraseAmnesiaAnimalsCholinergic AgentsCholinesterase InhibitorsCholinesterasesDisease Models, AnimalMaze LearningMiceMolecular Docking SimulationAcetylcholinesteraseCholinergic AgentsCholinesterase InhibitorsCholinesterasesCurcuminScopolamineacetylcholinesteraseAlzheimer’s diseaseamnesiabutyrylcholinesterasecurcumin analogsdockingEPMhippocampusNORTscopolamineY-maze

Identifiers

PMID35458662
PMCPMC9029618
OpenAlexW4223524063

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.